ACCUSIGN BZO, BIOSIGN BZO, STATUS BZO— 510(k) K991079

Substantially Equivalent

Princeton BioMeditech Corp.

FDA 510(k) clearance K991079 for ACCUSIGN BZO, BIOSIGN BZO, STATUS BZO, Substantially Equivalent on 1999-04-15. Applicant: Princeton BioMeditech Corp..

Clearance details

Applicant: Princeton BioMeditech Corp.
Product code: Code JXM
Advisory panel: Clinical Toxicology
Date received: 1999-03-26
Decision date: 1999-04-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.